Follitropin delta

Drug Profile

Follitropin delta

Alternative Names: FE-999049; Recombinant follicle-stimulating hormone - Ferring Pharmaceuticals; Recombinant FSH - Ferring; Rekovelle

Latest Information Update: 22 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ferring Pharmaceuticals
  • Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins; Recombinant proteins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered Female infertility

Most Recent Events

  • 04 Oct 2017 Ferring Pharmaceuticals plans a phase III trial for Female infertility in China, South Korea, Taiwan and Vietnam (NCT03296527)
  • 29 Jul 2017 Phase-III clinical trials in Female infertility in Japan (SC) (NCT03228680)
  • 27 Jul 2017 Ferring Pharmaceuticals plans a phase III trial for Female infertility in Japan (NCT03228680)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top